Boothbay Fund Management, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.17 - $5.31 $9,335 - $291,593	-54,914 Reduced 57.9%	39,934 $7,000
Q2 2022 Aug 15, 2022	SELL	$0.21 - $0.53 $113 - $286	-540 Reduced 0.57%	94,848 $24,000
Q3 2021 Nov 15, 2021	SELL	$1.01 - $1.82 $33,291 - $59,990	-32,962 Reduced 25.68%	95,388 $97,000
Q2 2021 Aug 16, 2021	BUY	$1.39 - $2.21 $24,169 - $38,427	17,388 Added 15.67%	128,350 $235,000
Q1 2021 May 17, 2021	BUY	$1.27 - $3.42 $122,252 - $329,216	96,262 Added 654.84%	110,962 $219,000
Q4 2020 Feb 12, 2021	BUY	$0.94 - $1.89 $13,818 - $27,783	14,700 New	14,700 $18,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.